Page last updated: 2024-08-24

trovafloxacin and Bacterial Pneumonia

trovafloxacin has been researched along with Bacterial Pneumonia in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (50.00)	18.2507
2000's	5 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carbon, C; Dunbar, L; Fogarty, C; Hagberg, L; Pullman, J; van Rensburg, DJ	1
Choudhri, S; Church, D; Grossman, C; Haverstock, D; Herman-Gnjidic, Z; Lode, H; McGivern, J	1
Daniel, R; de Kock, F; Pluck, N; Trémolières, F	1
Hopkins, S; Williams, D	1
Garau, J	1
Gené, RJ; Luna, CM	1
Mandell, LA	1
Chuah, SK; Gollapudi, S; Hanna, N; Rana, G; Reddy, U; Thadepalli, H	1
Carbon, C; Chau, F; Dautrey, S; Faurisson, F; Join-Lambert, OF; Köhler, T; Michéa-Hamzehpour, M; Pechère, J; Vissuzaine, C	1
Cupo, M; File, TM; Garau, J; Schlemmer, B; Young, C	1

Reviews

3 review(s) available for trovafloxacin and Bacterial Pneumonia

Article	Year
Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis. Respiratory medicine, 2003, Volume: 97, Issue:6 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Fluoroquinolones; Humans; Ketolides; Macrolides; Naphthyridines; Penicillins; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome	2003
[Is trovafloxacin an antibiotic exclusively for the treatment of respiratory infections?]. Enfermedades infecciosas y microbiologia clinica, 1998, Volume: 16 Suppl 2 Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Naphthyridines; Pneumonia, Bacterial; Respiratory Tract Infections	1998
[The role of trovafloxacin in the treatment of nosocomial pneumonia]. Medicina, 1999, Volume: 59 Suppl 1 Topics: Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Humans; Naphthyridines; Pneumonia, Bacterial; Risk Factors	1999

Trials

4 trial(s) available for trovafloxacin and Bacterial Pneumonia

Article	Year
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia. Respiratory medicine, 2003, Volume: 97, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aza Compounds; Clarithromycin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Naphthyridines; Pneumonia, Bacterial; Quinolines; Retrospective Studies; Treatment Outcome	2003
Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Drug Administration Schedule; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Penicillins; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae	1998
Safety of trovafloxacin in treatment of lower respiratory tract infections. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6 Topics: Acute Disease; Aged; Anti-Infective Agents; Bronchitis; Cardiovascular System; Chronic Disease; Community-Acquired Infections; Digestive System; Double-Blind Method; Europe; Fluoroquinolones; Humans; Naphthyridines; Nervous System; Pneumonia, Bacterial	1998
Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Drug Resistance, Microbial; Female; Fluoroquinolones; Gemifloxacin; Humans; Male; Middle Aged; Naphthyridines; Pneumonia, Bacterial	2001

Other Studies

3 other study(ies) available for trovafloxacin and Bacterial Pneumonia

Article	Year
[Use of trovafloxacin therapy in community-acquired pneumonia]. Medicina, 1999, Volume: 59 Suppl 1 Topics: Adult; Aged; Anti-Infective Agents; Child, Preschool; Community-Acquired Infections; Drug Administration Schedule; Fluoroquinolones; Hospitalization; Humans; Infant; Middle Aged; Naphthyridines; Pneumonia, Bacterial; Risk Factors; Severity of Illness Index	1999
Evaluation of trovafloxacin in the treatment of Klebsiella pneumoniae lung infection in tumour-bearing mice. The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:1 Topics: Animals; Anti-Infective Agents; Antibiotics, Antineoplastic; Ciprofloxacin; Daunorubicin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Klebsiella Infections; Klebsiella pneumoniae; Leukemia P388; Leukocyte Count; Male; Mice; Mice, Inbred DBA; Naphthyridines; Neoplasm Transplantation; Pneumonia, Bacterial; Recombinant Proteins	2000
Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:2 Topics: Acute Disease; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Lung; Male; Mutation; Naphthyridines; Pneumonia, Bacterial; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley	2001